These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22950997)

  • 1. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
    Rosen P; Pfister D; Young D; Petrovics G; Chen Y; Cullen J; Böhm D; Perner S; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S
    Urology; 2012 Oct; 80(4):749-53. PubMed ID: 22950997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
    Cullen J; Young D; Chen Y; Degon M; Farrell J; Sedarsky J; Baptiste W; Rosen P; Tolstikov V; Kiebish M; Kagan J; Srivastava S; Kuo HC; Moncur JT; Rosner IL; Narain N; Akmaev V; Petrovics G; Dobi A; McLeod DG; Srivastava S; Sesterhenn IA
    Eur Urol Focus; 2018 Dec; 4(6):818-824. PubMed ID: 28753864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for molecular differences in prostate cancer between African American and Caucasian men.
    Khani F; Mosquera JM; Park K; Blattner M; O'Reilly C; MacDonald TY; Chen Z; Srivastava A; Tewari AK; Barbieri CE; Rubin MA; Robinson BD
    Clin Cancer Res; 2014 Sep; 20(18):4925-34. PubMed ID: 25056375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos.
    Raymundo EM; Diwa MH; Lapitan MC; Plaza AB; Sevilleja JE; Srivastava S; Sesterhenn IA
    Prostate; 2014 Aug; 74(11):1079-85. PubMed ID: 24909781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
    Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
    Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
    Magi-Galluzzi C; Tsusuki T; Elson P; Simmerman K; LaFargue C; Esgueva R; Klein E; Rubin MA; Zhou M
    Prostate; 2011 Apr; 71(5):489-97. PubMed ID: 20878952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.
    Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL
    Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
    Furusato B; Tan SH; Young D; Dobi A; Sun C; Mohamed AA; Thangapazham R; Chen Y; McMaster G; Sreenath T; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
    Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):228-37. PubMed ID: 20585344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India.
    Rawal S; Young D; Williams M; Colombo M; Krishnappa R; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
    J Cancer; 2013; 4(6):468-72. PubMed ID: 23901346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of ERG-negative high-grade prostate cancers in African American men.
    Farrell J; Young D; Chen Y; Cullen J; Rosner IL; Kagan J; Srivastava S; McLEOD DG; Sesterhenn IA; Srivastava S; Petrovics G
    Mol Clin Oncol; 2014 Nov; 2(6):982-986. PubMed ID: 25279185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
    Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
    J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
    Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
    Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
    Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
    Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
    Petrovics G; Li H; Stümpel T; Tan SH; Young D; Katta S; Li Q; Ying K; Klocke B; Ravindranath L; Kohaar I; Chen Y; Ribli D; Grote K; Zou H; Cheng J; Dalgard CL; Zhang S; Csabai I; Kagan J; Takeda D; Loda M; Srivastava S; Scherf M; Seifert M; Gaiser T; McLeod DG; Szallasi Z; Ebner R; Werner T; Sesterhenn IA; Freedman M; Dobi A; Srivastava S
    EBioMedicine; 2015 Dec; 2(12):1957-64. PubMed ID: 26844274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
    Farrell J; Petrovics G; McLeod DG; Srivastava S
    Int J Mol Sci; 2013 Jul; 14(8):15510-31. PubMed ID: 23892597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
    Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
    J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial differences in prostate cancer growth: apoptosis and cell proliferation in Caucasian and African-American patients.
    Guo Y; Sigman DB; Borkowski A; Kyprianou N
    Prostate; 2000 Feb; 42(2):130-6. PubMed ID: 10617870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
    Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
    Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
    Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
    Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERG expression and prostatic adenocarcinoma.
    Verdu M; Trias I; Roman R; Rodon N; Garcia-Pelaez B; Calvo M; Dominguez A; Banus JM; Puig X
    Virchows Arch; 2013 Jun; 462(6):639-44. PubMed ID: 23703293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.